EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)VergleichsstudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

A comparison between rTMS and antidepressant medication on depressive symptom clusters in treatment-resistant depression

Iris Dalhuisen, Tom Biemans, Cornelis F Vos, Sophie Ter Hark, Iris van Oostrom, Jan Spijker, Ben Wijnen, Eric van Exel, Hans van Mierlo, Dieuwertje de Waardt, Martijn Arns, Indira Tendolkar und 2 weitere

European Archives of Psychiatry and Clinical Neuroscience · 2025

DOI: 10.1007/s00406-025-02012-0 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift European Archives of Psychiatry and Clinical Neuroscience, 2025. Verfasst von Iris Dalhuisen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands. iris.dalhuisen@radboudumc.nl. Hauptthemen laut MEDLINE: Antidepressive Agents, Antidepressive Agents, Tricyclic, Depressive Disorder, Treatment-Resistant, Outcome Assessment, Health Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antidepressive treatment outcomes can be assessed using sum scores from measurement scales, but symptom clusters may better capture the multidimensional structure of depression. Little is known about the comparative effectiveness of different treatment modalities on these clusters. We sought to evaluate the effects of rTMS and antidepressant medication on four symptom clusters and the extent to which these differ between treatments. In addition, we assessed whether baseline cluster scores predicted (non)response.

Methods

Data were obtained from two clinical trials (DETECT: rTMS vs. medication; PITA: tricyclic antidepressants). Primary outcomes were symptom cluster scores: ‘General Depression’, ‘Anxiety’, ‘Somatic Symptoms’ and ‘Insomnia’. In the primary analysis based on DETECT, a MANCOVA comparing rTMS with medication was performed. For validation, a MANCOVA was performed replacing medication data from DETECT with data from PITA. Baseline symptom cluster scores were compared between responders and non-responders, as well as treatment groups.

Results

In both the primary and validation analyses, no difference was seen between rTMS and medication on the symptom clusters. Similar patterns of response were observed in all groups, with ‘Insomnia’ showing the greatest effect of treatment. Baseline cluster scores did not predict treatment response.

Conclusions

We did not find a differential effect of rTMS or antidepressant medication on depressive symptom clusters. Both treatments demonstrated comparable response patterns for all clusters, and baseline cluster scores did not differ between responders and non-responders. Future studies with larger samples or more homogeneous treatments may elucidate the role of symptom clusters as a tool for more individualized treatment.

Trial registration

PITA NCT03548675 DETECT The Netherlands Trial Register NL7628.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsAntidepressive Agents, TricyclicDepressive Disorder, Treatment-ResistantOutcome Assessment, Health CareTranscranial Magnetic StimulationAdultAgedFemaleHumansMaleMiddle AgedSleep Initiation and Maintenance Disorders

Stichwörter der Autor:innen

AntidepressantsDepressionSymptom clustersTreatment resistancerTMS

Substanzen

Antidepressive AgentsAntidepressive Agents, Tricyclic

Autor:innen und Institutionen

  • Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands. iris.dalhuisen@radboudumc.nl.
  • Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Donders Institute for Brain Cognition and Behavior, Centre for Medical Neuroscience, Nijmegen, The Netherlands.
  • Antes, Parnassia Group, Rotterdam, The Netherlands.
  • Neurocare Clinics, Nijmegen, The Netherlands.
  • Depression Expertise Centre, Pro Persona Mental Health Care, Nijmegen, The Netherlands.

Förderung

  • ZonMw

Zitieren

APA

Dalhuisen, I., Biemans, T., Vos, C. F., Hark, S. T., van Oostrom, I., Spijker, J., Wijnen, B., van Exel, E., van Mierlo, H., de Waardt, D., Arns, M., Tendolkar, I., Janzing, J., & van Eijndhoven, P. (2025). A comparison between rTMS and antidepressant medication on depressive symptom clusters in treatment-resistant depression. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-025-02012-0

Vancouver

Dalhuisen I, Biemans T, Vos CF, Hark ST, van Oostrom I, Spijker J, et al. A comparison between rTMS and antidepressant medication on depressive symptom clusters in treatment-resistant depression. European Archives of Psychiatry and Clinical Neuroscience. 2025. doi:10.1007/s00406-025-02012-0

BibTeX
@article{Dalhuisen2025,
  author = {Dalhuisen, Iris and Biemans, Tom and Vos, Cornelis F and Hark, Sophie Ter and van Oostrom, Iris and Spijker, Jan and Wijnen, Ben and van Exel, Eric and van Mierlo, Hans and de Waardt, Dieuwertje and Arns, Martijn and Tendolkar, Indira and Janzing, Joost and van Eijndhoven, Philip},
  title = {A comparison between rTMS and antidepressant medication on depressive symptom clusters in treatment-resistant depression},
  journal = {European Archives of Psychiatry and Clinical Neuroscience},
  year = {2025},
  doi = {10.1007/s00406-025-02012-0}
}
Kostenlos starten →